On April 30, 2026, Boston Scientific Corp. held its Annual Meeting, where stockholders approved several amendments to the company’s charter, including the elimination of supermajority voting provisions and the approval of the Employee Stock Purchase Plan. The filing indicates significant support for the elected directors and the proposed changes, with notable vote counts such as 1,205 million votes in favor of increasing shares for the stock purchase plan.